Bayforest Capital LTD Cytokinetics Inc Transaction History
Bayforest Capital LTD
- $79.8 Billion
- Q4 2024
A detailed history of Bayforest Capital LTD transactions in Cytokinetics Inc stock. As of the latest transaction made, Bayforest Capital LTD holds 1,689 shares of CYTK stock, worth $72,610. This represents 0.1% of its overall portfolio holdings.
Number of Shares
1,689Holding current value
$72,610% of portfolio
0.1%Shares
1 transactions
Others Institutions Holding CYTK
# of Institutions
396Shares Held
114MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$631 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$512 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$462 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$265 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$122 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.05B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...